Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3263033 | 0.91 | ALDH1A1 (0.57) | KDM4EALDH1A1LMNAMAPK1MAPT | |
| SCHEMBL3262306 | 0.89 | KDM4E (0.55) | KDM4EALDH1A1LMNAMAPK1MAPT | |
| SCHEMBL3260174 | 0.89 | LMNA (0.55) | KDM4EALDH1A1LMNAMAPK1MAPT | |
| SCHEMBL3637912 | 0.88 | LMNA (0.56) | KDM4EALDH1A1LMNAMAPK1MAPT | |
| SCHEMBL3378990 | 0.87 | ALDH1A1 (0.53) | KDM4EALDH1A1LMNAMAPK1MAPT | |
| SCHEMBL3262940 | 0.86 | ALDH1A1 (0.56) | KDM4EALDH1A1LMNAMAPK1MAPT | |
| SCHEMBL13492873 | 0.85 | ATM (0.63) | KDM4EALDH1A1LMNAMAPK1MAPT | |
| SCHEMBL3235282 | 0.84 | MTNR1A (0.69) | KDM4EALDH1A1LMNAMAPK1MAPT | |
| SCHEMBL3637611 | 0.84 | MEN1 (0.62) | KDM4EALDH1A1LMNAMAPK1MAPT | |
| SCHEMBL3261033 | 0.83 | LMNA (0.55) | KDM4EALDH1A1LMNAMAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2149552-A1 | 5,6 substituted benzamide derivatives as modulators of EP2 receptors | Bayer Schering Pharma AG (DE) | 2010-02-03 | — | — | EP | claimed |
| EP-2149552-A1 | 5,6 substituted benzamide derivatives as modulators of EP2 receptors | Bayer Schering Pharma AG (DE) | 2010-02-03 | — | — | EP | disclosed |
| EP-2149552-A1 | 5,6 substituted benzamide derivatives as modulators of EP2 receptors | Bayer Schering Pharma AG (DE) | 2010-02-03 | — | — | EP | disclosed |